Zobrazeno 1 - 8
of 8
pro vyhledávání: '"E N Khoseva"'
Autor:
O M Lesnyak, E N Khoseva, L V Menshikova, T V Antonova, I M Ivygina, E V Kapustina, I I Veytsman, I B Belousova, E I Sitnikova, S Yu Shkireeva, O B Bozhko, N V Bezlyudnaya, L Kh Gilyazeva, N Yu Kozhevnikova, Yu V Titova, E N Chikina, N N Kalinina, I E Prokhorova
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 2, Pp 7-10 (2014)
To assess the influence of informing patients with postmenopausal osteoporosis about the their probability of 10-year absolute fracture risk calculated by FRAX tool on the patient ’s decision to start treatment and their adherence to therapy during
Externí odkaz:
https://doaj.org/article/1b62bf67c91b4f048b4e50c97881e0fb
Publikováno v:
Гинекология, Vol 14, Iss 1, Pp 4-7 (2012)
Externí odkaz:
https://doaj.org/article/a8f64409bf1d43a782c0123fb869d3a4
Autor:
E. N. Khoseva, T. E. Morozova
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 40-45 (2018)
In the review stages of formation and the main problems of a pharmacovigilance in Russia at the present stage are considered: regulatory procedures, the reporting of the doctor and the pharmaceutical company, participation of patients, monitoring of
Externí odkaz:
https://doaj.org/article/208c181ad9b54c89a54a006efba722fe
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 2, Pp 205-210 (2015)
Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases is focused. Mode of ASA disaggregation action is discussed. Data of randomized controlled trials on ASA efficacy and safety in primary and secondary pre
Externí odkaz:
https://doaj.org/article/f502301a41e6404390fa16818ca22166
Autor:
N N Kalinina, S Yu Shkireeva, L Kh Gilyazeva, I E Prokhorova, I M Ivygina, E V Kapustina, E I Sitnikova, T V Antonova, I I Veytsman, O B Bozhko, E N Khoseva, N Yu Kozhevnikova, L V Menshikova, E N Chikina, I B Belousova, Olga Lesnyak, N V Bezlyudnaya, Yu V Titova
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 2, Pp 7-10 (2014)
To assess the influence of informing patients with postmenopausal osteoporosis about the their probability of 10-year absolute fracture risk calculated by FRAX tool on the patient ’s decision to start treatment and their adherence to therapy during
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 8, Iss 2, Pp 205-210 (2015)
Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases is focused. Mode of ASA disaggregation action is discussed. Data of randomized controlled trials on ASA efficacy and safety in primary and secondary pre
Autor:
S Iu, Martsevich, S N, Tolpygina, Iu V, Lukina, V P, Voronina, N V, Kiseleva, E S, Boĭchenko, R É, Dubinskaia, E N, Khoseva
Publikováno v:
Kardiologiia. 52(1)
The purpose of the study was a comparative study of antiplatelet activity of acetylsalicylic acid drugs, produced in gastro-resistant form trombopol 75 mg and aspirin cardio 100 mg in patients with high risk of cardiovascular events. Effect of trombo
Autor:
D V, Preobrazhenskiĭ, N I, Nekrasova, E N, Khoseva, A, Arystanova, I V, Talyzina, S A, Pataraia
Publikováno v:
Kardiologiia. 51(4)
Torasemide is a loop diuretic and has been used for the treatment of both acute and chronic congestive heart failure (CHF) and arterial hypertension (AH). Torasemide is similar to other loop diuretics in terms of its mechanism of diuretic action. It